Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease
NCT00004423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2015-03-25
Summary
OBJECTIVES:
I. Assess the efficacy and safety of 4-aminosalicylic acid in patients with active Crohn's disease of the small bowel.
Conditions
Interventions
- DRUG
-
-aminosalicylic acid
Sponsors & Collaborators
-
University of Vermont
lead OTHER
Principal Investigators
-
James A. Vecchio · University of Vermont
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-12-31
- Completion
- 1998-03-31
More Related Trials
-
VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease
NCT00114465 ·Status: COMPLETED ·Phase: PHASE4
-
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
NCT01258205 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of HMPL-004 in Subjects With Crohn's Disease
NCT00655733 ·Status: COMPLETED ·Phase: PHASE2
-
Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
NCT04522271 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease
NCT00445432 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
NCT00077779 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Entocort for Children With Crohn's Disease
NCT01444092 ·Status: COMPLETED ·Phase: PHASE3
-
CP-461 for the Treatment of Crohn's Disease
NCT00042055 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery
NCT04160325 ·Status: RECRUITING ·Phase: NA
-
Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose
NCT00868660 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
NCT00446433 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.
NCT00175292 ·Status: COMPLETED ·Phase: PHASE3
-
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
NCT03440385 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
NCT00102921 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease
NCT04151225 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
NCT01224171 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease
NCT02499783 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Brodalumab in Adults With Crohn's Disease
NCT01199302 ·Status: TERMINATED ·Phase: PHASE2
-
STA-5326 in Crohn's Disease Patients
NCT00088062 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Corticosteroid Dosage for Crohn's Disease Flare
NCT02392286 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission
NCT01820247 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
NCT01059344 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
NCT00409682 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis
NCT01177228 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
NCT00073021 ·Status: COMPLETED ·Phase: PHASE3